Clinical Trials List
Protocol NumberB1621002
Completed
2012-01-01 - 2013-06-30
Phase II
Terminated4
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- - - Division of Endocrinology
- Kuo-Chin Huang Division of Endocrinology
- CHIH-YUAN WANG CHIH-YUAN WANG Division of Endocrinology
- 李弘元 Division of Endocrinology
- 張恬君 Division of Endocrinology
- CHIH-YUAN WANG Division of Endocrinology
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- 林立偉 Division of Endocrinology
- Shuen-Fu Weng Division of Endocrinology
- Chung-Huei Hsu Division of Endocrinology
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Completed
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
300 participants
